Product: Ranitidine 150 mg tablets, 130 count bottles, NDC 37808-196-04.
Reason for recall: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Recall initiated: 20191226
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated